Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Pulante Pharmaceutical, also known as Sinopharm Pulante (Qinghai) Pharmaceutical, is a specialized pharmaceutical company based in Xining, China, that focuses on the development and manufacture of Traditional Chinese Medicine (TCM) and Tibetan medicines. As a subsidiary of Sinopharm Tongjitang (Guizhou) Pharmaceutical, the company operates advanced production lines for hard capsules, tablets, granules, and liniments, and is recognized as a national-level "Green Factory." Its key product, the Pingfeng Bishu Capsule, is utilized for treating respiratory conditions such as rhinitis and sinusitis. The company is currently undergoing significant technical upgrades to expand its production capacity for TCM formula granules to 500 tons annually. It is also recognized as a "Specialized and Sophisticated" enterprise within the Qinghai province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinghai Pulante Pharmaceutical.